Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy, safety and neonatal effects of oxycodone for labour pain
2024-516495-15-00Phase 4Authorised
- Sponsor
- Pohjois-Savon hyvinvointialue
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxycodone, sponsored by Pohjois-Savon hyvinvointialue. Primary endpoint: Maternal and umbilical cord oxycodone concentration at birth. Planned start Aug 2024; status: authorised.
02
Drugs
oxycodone
Beyond the preview
Go deeper on 2024-516495-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516495-15-00.